Revenue
4.14 billion USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 4142000000 USD Source
Fundies. English
TEVA PHARMACEUTICAL INDUSTRIES LTD
EDGARAnnual consolidated revenue for 2025: about USD 17.26B, using the latest reported figures. The previous period, 2024, was about USD 16.54B.
Latest quarter
- Cash and cash equivalents
- 3.66 billion USD Source
Exact value
3655000000 USD
- Long-term debt including current maturities
- 28.8 billion USD Source
Exact value
28829000000 USD
- Shares outstanding
- Not available
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
14.1 billion USD
2025-07-01 – 2026-06-30
Net income
706 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
1.9 billion USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 369000000 USD · 2025-07-01 – 2025-09-30 Source
- Operating cash flow: 1649000000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 491000000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -40000000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 411000000 USD · 2026-04-01 – 2026-06-30 Source
Capital expenditure
522 million USD
2022-07-01 – 2023-06-30
Exact inputs and evidence
- Capital expenditure: 406000000 USD · 2022-01-01 – 2022-09-30 Source
- Capital expenditure: 284000000 USD · 2022-01-01 – 2022-06-30 Source
- Capital expenditure: 548000000 USD · 2022-01-01 – 2022-12-31 Source
- Capital expenditure: 406000000 USD · 2022-01-01 – 2022-09-30 Source
- Capital expenditure: 139000000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 119000000 USD · 2023-04-01 – 2023-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 8 of 11 periods available· newest 2022-12-31
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 3 of 11 periods available· newest 2017-12-31
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+4.3%Prior period
USD 16.54 billion
–
Current period
USD 17.26 billion
–
Exact inputs and evidence
17258000000 − 16544000000 = 714000000 USD
16544000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source17258000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.05 billionPrior period
−USD 1.64 billion
–
Current period
USD 1.41 billion
–
Exact inputs and evidence
1410000000 − -1639000000 = 3049000000 USD
-1639000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1410000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+32.2%Prior period
USD 1.25 billion
–
Current period
USD 1.65 billion
–
Exact inputs and evidence
1649000000 − 1247000000 = 402000000 USD
1247000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1649000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 17.26 billion 100% of revenue
- Operating costs Derived USD 15.1 billion 88% of revenue
- Operating income USD 2.16 billion 12% of revenue
- Tax, interest and other Derived USD 747 million 4.3% of revenue
- Net income USD 1.41 billion 8.2% of revenue
Cash
- Operating cash flow USD 1.65 billion 9.6% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 90%
- 2017 Operating loss: operating costs were 180% of revenue.
- 2018 Operating loss: operating costs were 109% of revenue.
- 2019 Operating loss: operating costs were 103% of revenue.
- 2020 Operating loss: operating costs were 121% of revenue.
- 2021 89%
- 2022 Operating loss: operating costs were 115% of revenue.
- 2023 Net loss: net income was −3.5% of revenue.
- 2024 Operating loss: operating costs were 102% of revenue.
- 2025 88%
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-07 – 2016-12-31 | 21903000000 | 19749000000 Derived | 2154000000 | 1825000000 Derived | 329000000 | 2989000000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 21853000000 | 39337000000 Derived | -17484000000 | -1219000000 Derived | -16265000000 | 1351000000 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 18271000000 | 19908000000 Derived | -1637000000 | 513000000 Derived | -2150000000 | 1795000000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 16887000000 | 17330000000 Derived | -443000000 | 556000000 Derived | -999000000 | 223000000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 16659000000 | 20231000000 Derived | -3572000000 | 418000000 Derived | -3990000000 | 638000000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 15878000000 | 14162000000 Derived | 1716000000 | 1299000000 Derived | 417000000 | 236000000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 14925000000 | 17122000000 Derived | -2197000000 | 249000000 Derived | -2446000000 | 1042000000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 15846000000 | 15413000000 Derived | 433000000 | 992000000 Derived | -559000000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 16544000000 | 16847000000 Derived | -303000000 | 1336000000 Derived | -1639000000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 17258000000 | 15101000000 Derived | 2157000000 | 747000000 Derived | 1410000000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 17.3B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 19652000000 |
|
| 2017 | Revenue | 21853000000 |
|
| 2018 | Revenue | 18271000000 |
|
| 2019 | Revenue | 16887000000 |
|
| 2020 | Revenue | 16659000000 |
|
| 2021 | Revenue | 15878000000 |
|
| 2022 | Revenue | 14925000000 |
|
| 2023 | Revenue | 15846000000 |
|
| 2024 | Revenue | 16544000000 |
|
| 2025 | Revenue | 17258000000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
4.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | -16.4% |
|
| 2019 | Year over year | -7.6% |
|
| 2020 | Year over year | -1.4% |
|
| 2021 | Year over year | -4.7% |
|
| 2022 | Year over year | -6% |
|
| 2023 | Year over year | 6.2% |
|
| 2024 | Year over year | 4.4% |
|
| 2025 | Year over year | 4.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 12.5% 2025
Net margin 8.2% 2025
Free cash flow margin 7% 2022
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Operating margin | 17.1% |
|
| 2017 | Operating margin | -80% |
|
| 2018 | Operating margin | -9% |
|
| 2019 | Operating margin | -2.6% |
|
| 2020 | Operating margin | -21.4% |
|
| 2021 | Operating margin | 10.8% |
|
| 2022 | Operating margin | -14.7% |
|
| 2023 | Operating margin | 2.7% |
|
| 2024 | Operating margin | -1.8% |
|
| 2025 | Operating margin | 12.5% |
|
| 2015 | Net margin | 8.1% |
|
| 2017 | Net margin | -74.4% |
|
| 2018 | Net margin | -11.8% |
|
| 2019 | Net margin | -5.9% |
|
| 2020 | Net margin | -24% |
|
| 2021 | Net margin | 2.6% |
|
| 2022 | Net margin | -16.4% |
|
| 2023 | Net margin | -3.5% |
|
| 2024 | Net margin | -9.9% |
|
| 2025 | Net margin | 8.2% |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | 6.2% |
|
| 2018 | Free cash flow margin | 9.8% |
|
| 2019 | Free cash flow margin | 1.3% |
|
| 2020 | Free cash flow margin | 3.8% |
|
| 2021 | Free cash flow margin | 1.5% |
|
| 2022 | Free cash flow margin | 7% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 1.6B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | 2225000000 |
|
| 2018 | Operating cash flow | 2446000000 |
|
| 2019 | Operating cash flow | 748000000 |
|
| 2020 | Operating cash flow | 1216000000 |
|
| 2021 | Operating cash flow | 798000000 |
|
| 2022 | Operating cash flow | 1590000000 |
|
| 2023 | Operating cash flow | 1368000000 |
|
| 2024 | Operating cash flow | 1247000000 |
|
| 2025 | Operating cash flow | 1649000000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 1B 2022
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | 1351000000 |
|
| 2018 | Free cash flow | 1795000000 |
|
| 2019 | Free cash flow | 223000000 |
|
| 2020 | Free cash flow | 638000000 |
|
| 2021 | Free cash flow | 236000000 |
|
| 2022 | Free cash flow | 1042000000 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
80.6% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Liabilities / assets | 44.8% |
|
| 2017 | Liabilities / assets | 73.5% |
|
| 2018 | Liabilities / assets | 74% |
|
| 2019 | Liabilities / assets | 73.8% |
|
| 2020 | Liabilities / assets | 78.2% |
|
| 2021 | Liabilities / assets | 76.4% |
|
| 2022 | Liabilities / assets | 80.5% |
|
| 2023 | Liabilities / assets | 81.3% |
|
| 2024 | Liabilities / assets | 85.5% |
|
| 2025 | Liabilities / assets | 80.6% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
1.04× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Current assets / current liabilities | 1.41× |
|
| 2017 | Current assets / current liabilities | 0.86× |
|
| 2018 | Current assets / current liabilities | 0.96× |
|
| 2019 | Current assets / current liabilities | 0.98× |
|
| 2020 | Current assets / current liabilities | 0.99× |
|
| 2021 | Current assets / current liabilities | 1.14× |
|
| 2022 | Current assets / current liabilities | 1.05× |
|
| 2023 | Current assets / current liabilities | 1.02× |
|
| 2024 | Current assets / current liabilities | 0.98× |
|
| 2025 | Current assets / current liabilities | 1.04× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-07 – 2016-12-31 | USD 329 million Exact valueExact value: 329000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.89 billion Exact valueExact value: 3890000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 901 million Exact valueExact value: 901000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.99 billion Calculation and evidence3890000000 − 901000000 USD Exact free cash flow: 2989000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 16.27 billion Exact valueExact value: -16265000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.23 billion Exact valueExact value: 2225000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 874 million Exact valueExact value: 874000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.35 billion Calculation and evidence2225000000 − 874000000 USD Exact free cash flow: 1351000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 2.15 billion Exact valueExact value: -2150000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.45 billion Exact valueExact value: 2446000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 651 million Exact valueExact value: 651000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.8 billion Calculation and evidence2446000000 − 651000000 USD Exact free cash flow: 1795000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 999 million Exact valueExact value: -999000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 748 million Exact valueExact value: 748000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 525 million Exact valueExact value: 525000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 223 million Calculation and evidence748000000 − 525000000 USD Exact free cash flow: 223000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 3.99 billion Exact valueExact value: -3990000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.22 billion Exact valueExact value: 1216000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 578 million Exact valueExact value: 578000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 638 million Calculation and evidence1216000000 − 578000000 USD Exact free cash flow: 638000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | USD 417 million Exact valueExact value: 417000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 798 million Exact valueExact value: 798000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 562 million Exact valueExact value: 562000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 236 million Calculation and evidence798000000 − 562000000 USD Exact free cash flow: 236000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 2.45 billion Exact valueExact value: -2446000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.59 billion Exact valueExact value: 1590000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 548 million Exact valueExact value: 548000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.04 billion Calculation and evidence1590000000 − 548000000 USD Exact free cash flow: 1042000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 559 million Exact valueExact value: -559000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.37 billion Exact valueExact value: 1368000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 1.64 billion Exact valueExact value: -1639000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.25 billion Exact valueExact value: 1247000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 1.41 billion Exact valueExact value: 1410000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.65 billion Exact valueExact value: 1649000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
836 filings · 15,894 latest values · 15,894 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000818686, 818686, Q2, Q3, TEVA, edgar:818686
Also known as TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICAL INDUSTRIES LTD, Teva Pharmaceutical Industries Ltd